Loading…

Incidence of malignant tumors of larynx and their treatment

We retrospectively analyzed patients with larynx cancer that were treated at ENT Clinics in Sarajevo in the last 5 years. According to the tumor site, TNM classification, operative procedure and postoperative treatment we found the following: Over the last 5 years 156 patients underwent surgical tre...

Full description

Saved in:
Bibliographic Details
Published in:Biomolecules & biomedicine 2004-11, Vol.4 (4), p.25-27
Main Authors: Alagić-Smailbegović, Jasminka, Kapidzić, Adnan, Sutalo, Kamenko, Resić, Mudzahid, Hadzić, Edina
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We retrospectively analyzed patients with larynx cancer that were treated at ENT Clinics in Sarajevo in the last 5 years. According to the tumor site, TNM classification, operative procedure and postoperative treatment we found the following: Over the last 5 years 156 patients underwent surgical treatment--143 (91,6%) male and 23 (8.4%) female. According to the age 1 patient belonged in the age group 30-40 years (0.64%), 25 in the age group 40-50 years (16%), 51 in the age group 50-60 (32.7%), and 79 were over 60 years of age (50.6%). Of those 145 were smokers (93%), and 11 non-smokers (7%). Histological findings showed 100% cases with squamous cell cancer. Most of the patients were surgically treated with total laryngeoctomy with unilateral or bilateral dissection and thyroidectomy or lobectomy (29%) or total laryngectomy with thyroidectomy or lobectomy (23%), total laryngectomy (22%). The rest of the patients underwent total laryngeoctomy with unilateral or bilateral dissection (16%) chordectomy (4%), supraglottic laryngectomy (3%), hemilaryngectomy (2%) and hemilaryngectomy with dissection (1%) All patients were postoperatively irradiated and chemotherapy was combined with irradiation only in younger patients.
ISSN:1512-8601
2831-0896
1840-4812
2831-090X
DOI:10.17305/bjbms.2004.3355